Stifel says Inspire Medical’s (INSP) reimbursement CPT code “merry-go-round took a turn for the worse this morning” as two Medicare Administrative Contractors – CGS and Noridian – pulled CPT code 64568 for HGNS and are “seemingly redirecting” Inspire surgery back to the former code 64582, though “details are still (somewhat) scant.” For now, the stock is under significant pressure as the recent reimbursement driven rally is essentially erased and the firm sees it returning to a “show me” execution narrative, though Stifel reiterates a Buy rating on Inspire, calling it “a business fully funded in the midst of a product cycle.” In morning trading, Inspire shares are down $24.80, or 21%, to $93.47.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INSP:
